
Does rapamyacin significantly increase the lifespan of dogs?
13
Ṁ1kṀ182Feb 1
70%
chance
1H
6H
1D
1W
1M
ALL
According this ongoing tufts study https://vet.tufts.edu/clinical-trials/dog-aging-project-test-rapamycin-aging-dogs-triad
Close date updated to 2025-01-01 6:59 pm
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
Sort by:
What exists today is safety, not lifespan: a 10-week placebo-controlled trial in 24 dogs (2017) and a 6-month trial in 17 dogs (2023) found no clinically significant adverse events; neither measured lifespan. The lifespan test is TRIAD, funded through November 2029. Both records: https://w0lph.github.io/k9/trials/
@DismalScientist the study seems to have been suspended possibly? Are you planning to resolve N/A or NO or extend the close date, if it isn't gonna be studied for at least a while?
People are also trading
Related questions
Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
11% chance
Will the TRIAD trial report that rapamycin significantly extended lifespan in dogs by December 31, 2031?
45% chance
Will the FDA conditionally approve a drug to extend lifespan or healthspan in dogs before January 1, 2028?
31% chance
Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
32% chance
Which species will get the first regulator-approved drug with lifespan extension as the indication?
What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
What percent of those taking rapamycin to slow aging will comment a positive or neutral review?
56% chance